124 related articles for article (PubMed ID: 18037105)
1. Elevated fibroblast growth factor 23 in a patient with metastatic prostate cancer and hypophosphatemia.
Cotant CL; Rao PS
Am J Kidney Dis; 2007 Dec; 50(6):1033-6. PubMed ID: 18037105
[No Abstract] [Full Text] [Related]
2. Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.
Hannan FM; Athanasou NA; Teh J; Gibbons CL; Shine B; Thakker RV
Eur J Endocrinol; 2008 Feb; 158(2):265-71. PubMed ID: 18230836
[TBL] [Abstract][Full Text] [Related]
3. Tumor-induced osteomalacia: lessons learned.
Lewiecki EM; Urig EJ; Williams RC
Arthritis Rheum; 2008 Mar; 58(3):773-7. PubMed ID: 18311810
[TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.
Endo I; Fukumoto S; Ozono K; Namba N; Tanaka H; Inoue D; Minagawa M; Sugimoto T; Yamauchi M; Michigami T; Matsumoto T
Bone; 2008 Jun; 42(6):1235-9. PubMed ID: 18396126
[TBL] [Abstract][Full Text] [Related]
5. Cinacalcet in the management of tumor-induced osteomalacia.
Geller JL; Khosravi A; Kelly MH; Riminucci M; Adams JS; Collins MT
J Bone Miner Res; 2007 Jun; 22(6):931-7. PubMed ID: 17352646
[TBL] [Abstract][Full Text] [Related]
6. Tumour-associated osteomalacia and hypoglycaemia in a patient with prostate cancer: is Klotho involved?
Latifyan SB; Vanhaeverbeek M; Klastersky J
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25406200
[TBL] [Abstract][Full Text] [Related]
7. [FGF-23].
Miyauchi A
Nihon Rinsho; 2004 Feb; 62 Suppl 2():378-84. PubMed ID: 15035156
[No Abstract] [Full Text] [Related]
8. [Clinical usefulness of the determination of fibroblast growth factor 23 in the evaluation of patients with osteomalacia].
Gifre L; Martínez de Osaba MJ; Monegal A; Guañabens N; Peris P
Med Clin (Barc); 2014 May; 142(10):447-50. PubMed ID: 24629692
[TBL] [Abstract][Full Text] [Related]
9. FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study.
Schouten BJ; Hunt PJ; Livesey JH; Frampton CM; Soule SG
J Clin Endocrinol Metab; 2009 Jul; 94(7):2332-7. PubMed ID: 19366850
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.
Bai X; Miao D; Li J; Goltzman D; Karaplis AC
Endocrinology; 2004 Nov; 145(11):5269-79. PubMed ID: 15284207
[TBL] [Abstract][Full Text] [Related]
11. Disorders of phosphate metabolism.
Leung J; Crook M
J Clin Pathol; 2019 Nov; 72(11):741-747. PubMed ID: 31467040
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia.
Imel EA; Peacock M; Pitukcheewanont P; Heller HJ; Ward LM; Shulman D; Kassem M; Rackoff P; Zimering M; Dalkin A; Drobny E; Colussi G; Shaker JL; Hoogendoorn EH; Hui SL; Econs MJ
J Clin Endocrinol Metab; 2006 Jun; 91(6):2055-61. PubMed ID: 16551733
[TBL] [Abstract][Full Text] [Related]
13. Sporadic adult-onset hypophosphatemic osteomalacia caused by excessive action of fibroblast growth factor 23.
Hoshino C; Satoh N; Sugawara S; Kuriyama C; Kikuchi A; Ohta M
Intern Med; 2008; 47(5):453-7. PubMed ID: 18310982
[TBL] [Abstract][Full Text] [Related]
14. Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?
Bhan I; Shah A; Holmes J; Isakova T; Gutierrez O; Burnett SM; Jüppner H; Wolf M
Kidney Int; 2006 Oct; 70(8):1486-94. PubMed ID: 16941023
[TBL] [Abstract][Full Text] [Related]
15. Neurofibromatosis type 1 associated with hypophosphatemic osteomalacia due to hypersecretion of fibroblast growth factor 23: a case report.
Obo T; Koriyama N; Tokito A; Ogiso K; Nishio Y
J Med Case Rep; 2020 May; 14(1):56. PubMed ID: 32384911
[TBL] [Abstract][Full Text] [Related]
16. Advanced prostate cancer as a cause of oncogenic osteomalacia: an underdiagnosed condition.
Mak MP; da Costa e Silva VT; Martin RM; Lerario AM; Yu L; Hoff PM; de Castro G
Support Care Cancer; 2012 Sep; 20(9):2195-7. PubMed ID: 22552356
[TBL] [Abstract][Full Text] [Related]
17. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.
Sánchez Fructuoso AI; Maestro ML; Calvo N; De La Orden V; Pérez Flores I; Vidaurreta M; Valero R; Fernández-Pérez C; Barrientos A
Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451
[TBL] [Abstract][Full Text] [Related]
18. Hypophosphataemia due to FGF-23 producing B cell non-Hodgkin's lymphoma.
Elderman JH; Wabbijn M; de Jongh F
BMJ Case Rep; 2016 Apr; 2016():. PubMed ID: 27118742
[TBL] [Abstract][Full Text] [Related]
19. Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia.
Brown WW; Jüppner H; Langman CB; Price H; Farrow EG; White KE; McCormick KL
J Clin Endocrinol Metab; 2009 Jan; 94(1):17-20. PubMed ID: 18854401
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic osteomalacia--a complex dance of factors.
Carpenter TO
N Engl J Med; 2003 Apr; 348(17):1705-8. PubMed ID: 12711747
[No Abstract] [Full Text] [Related]
[Next] [New Search]
